Jennifer Creel
Nessuna posizione attualmente
Profilo
Jennifer Creel is former Chief Financial Officer of ADC Therapeutics SA and former Senior Director-Global Business Planning at Celgene Corp.
She received an undergraduate degree from The College of William & Mary and an MBA from the University of Virginia Darden School of Business.
Precedenti posizioni note di Jennifer Creel
Società | Posizione | Fine |
---|---|---|
ADC THERAPEUTICS SA | Director of Finance/CFO | 19/12/2022 |
CELGENE | Corporate Officer/Principal | 01/01/2020 |
Formazione di Jennifer Creel
The College of William & Mary | Undergraduate Degree |
University of Virginia Darden School of Business | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
ADC THERAPEUTICS SA | Health Technology |
Aziende private | 1 |
---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |